BSE filing, NSE: MANORAMA. Summary written from the filing by ALFA Finder's alert engine.
Manorama Industries Ltd: key numbers
- Share price
- ₹1,801.40
- Market cap
- ₹11,371 Cr
- Revenue (annual)
- ₹1,367 Cr
- Net profit (annual)
- ₹224.9 Cr
- P/E (TTM)
- 46.1×Sector 26.2×
- Promoter holding
- 51.38%-2.94% QoQ
- FII holding
- 4.16%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Manorama Industries Ltd
All →Manorama Industries Annual General Meeting
Manorama Industries Limited announced the voting results of its postal ballot, confirming the appointment of Dr. Rohini Tiwari as a Non-Executive Independent Director.
Manorama Industries Other Announcement
Manorama Industries submitted the Regulation 74(5) compliance certificate for the quarter ended September 30, 2026, confirming dematerialization activities processed by its RTA.
Manorama Industries Capital Structure Change
Manorama Industries' board approved up to Rs.30 Crore in capital infusions across three wholly-owned subsidiaries. The funds target working capital and general corporate purposes in Benin, Togo and Ivory Coast.
- Value
- ₹30.00 Cr
Manorama Industries Annual General Meeting
Manorama Industries issued a postal ballot notice to appoint Dr. Rohini Tiwari as Non-Executive Independent Director. E-voting window runs September 19 to October 18, 2026.
Manorama Industries Management Change
Manorama Industries Limited has appointed Dr. Rohini Tiwari as a Non-Executive Independent Director, while Mudit Kumar Singh concluded his tenure on the board.
Manorama Industries Board Meeting Outcome
Manorama Industries approved the appointment of an additional director, postal ballot processes, and a combined ₹75 Crore capital infusion into six of its wholly owned subsidiaries.
- Value
- ₹75.00 Cr
Other merger & restructuring announcements
All →Quint Digital Merger & Restructuring
Quint Digital's board approved a Rule 10b5-1 trading plan and the incorporation of a wholly owned overseas subsidiary. No investment amount was disclosed.
Hexaware Technologies Merger & Restructuring
Hexaware Technologies approved a slump sale of its step-down subsidiary Tech SMC Square India to Tech SMC Squared (GCC) India, a related-party deal. Consideration is cash, yet to be set by a registered valuer.
- Execution
- Expected completion by 30 June 2027; agreement date stated as 1 December 2026
Emkay Global Financial Services Merger & Restructuring Worth ₹2.75 Cr
Emkay Global agreed to sell its Wealth Management Business to a step-down subsidiary, Emkay Wealth Advisory, for Rs. 2.75 Crore cash. Completion is expected by 26 January 2027.
- Value
- ₹2.75 Cr
- Execution
- Completion expected by 26 January 2027
TVS Holdings Merger & Restructuring
TVS Holdings forwarded TVS Motor's board outcome of October 28, 2026 approving acquisition of Harita ARC and a composite scheme of amalgamation and demerger. The scheme is subject to stock exchange, SEBI, NCLT and shareholder approvals.
Emkay Global Financial Services Merger & Restructuring Worth ₹30 Cr
Emkay Global approved transferring two subsidiaries to new subsidiary ECPL and slump-selling its wealth business. Up to Rs.30 Crore rights investment in ECPL was also approved.
- Value
- ₹30.00 Cr
- Execution
- Divestment completion expected within 90 days of SPA execution, subject to regulatory approvals
Fortis Healthcare Merger & Restructuring Worth ₹277 Cr
Fortis subsidiary International Hospital acquired Suguna Ramaiah Hospitals' business, operations, land and building for Rs 277 Crore cash. The deal was consummated today, strengthening Bengaluru presence.
- Value
- ₹277.0 Cr